Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine adductor canal block after TKA
ChiCTR2400093350Phase 4Recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain comparing Liposomal bupivacaine arm with Ropivacaine arm (2 arms). Primary endpoint: Postoperative visual analogue scale (VAS) pain score. Started Dec 2024; status: recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400093350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093350.